Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
CRISPR Therapeutics AG Income Statement Banner

CRISPR Therapeutics AG Income Statement

CRSP Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
0.000247.000K5.164M40.997M3.124M289.590M543.000K913.081M436.000K371.206M
Cost of Revenue
1.513M12.573M42.238M69.800M113.773M179.362M269.407M17.953M110.250M130.250M
Gross Profit
-1.513m-12.326m-37.074m-28.803m-110.649m110.228M-268.864m895.128M-109.814m240.956M
Operating Expense
6.627M25.976M73.294M105.645M162.067M242.850M354.978M539.553M563.347M463.494M
Operating Income
-6.627m-25.729m-68.130m-64.648m-158.943m46.740M-354.435m373.528M-673.161m-222.538m
Other Income Expense
-236.000k16.000K78.512M-197.000k-5.485m20.566M-176.000k-1.882m-762.000k0.000
Total Other Income Expense
-236.000k-92.000k45.412M-1.960m-5.485m20.566M6.379M6.003M22.661M71.816M
Pretax Income
-6.863m-25.821m-22.718m-66.608m-164.428m67.306M-348.056m379.531M-650.500m-150.722m
Tax Provision
-63.000k7.000K484.000K1.749M553.000K448.000K809.000K1.870M-325.000k2.888M
Net Income
-6.800m-25.828m-23.202m-68.357m-164.981m66.858M-348.865m377.661M-650.175m-153.610m
Basic EPS
-0.230-0.880-1.890-1.710-3.4401.230-5.2904.970-8.360-1.940
Diluted EPS
-0.230-0.880-1.890-1.710-3.4401.170-5.2904.700-8.360-1.940
Basic Average Shares
29.298M29.298M12.257M39.975M47.960M54.392M65.950M75.949M77.747M79.221M
Diluted Average Shares
29.298M29.298M12.257M40.057M47.964M56.933M65.950M80.393M77.747M79.221M
Total Expenses
6.627M25.976M73.294M105.645M162.067M242.850M354.978M539.553M673.597M593.744M
Interest Income
0.0000.0000.0000.0000.00010.033M0.0000.0000.0000.000
Interest Expense
0.000108.000K8.050M0.0000.0000.0000.0000.0000.0000.000
EBITDA
-6.589m-25.586m-13.668m-61.624m-155.424m51.465M-345.251m391.481M-648.989m-202.701m
Depreciation & Amortization
38.000K127.000K1.000M3.024M3.519M4.725M9.184M17.953M24.172M19.837M